Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a Two-Antibiotic cocktail prevent infections after water breaks?

NCT ID NCT07563504

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether giving two antibiotics (ampicillin and gentamicin) instead of one (ampicillin alone) can better prevent infections in pregnant women whose water breaks before labor starts. About 320 women at term will be randomly assigned to one of the two treatments. The goal is to reduce chorioamnionitis (a serious infection of the amniotic sac) and other complications for both mother and baby.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ampicillin and gentamicin (antibiotics)
What this could lead to
If successful, this could show that adding gentamicin to standard care reduces serious infections in mothers and newborns after membrane rupture.
What could go wrong
This is a single-center trial with 320 participants, so results may not apply broadly. Gentamicin carries risks of kidney and hearing issues, though these are monitored.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 320 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Singleton pregnancy * Cephalic (vertex) presentation * Term gestation of 37+0 weeks or more based on obstetric dating * Confirmed prelabour rupture of membranes * Duration of prelabour rupture of membranes 12 hours or less at the time of enrolment * Unknown or negative Group B Streptococcus status in the current pregnancy * Clear amniotic fluid at presentation * Afebrile with no clinical signs of intra-amniotic infection at admission * Able to provide written informed consent * Planned delivery at a participating study hospital Exclusion Criteria: * Preterm prelabour rupture of membranes before 37+0 weeks * Fever of 38.0°C or higher, maternal tachycardia, uterine tenderness, purulent discharge, or other clinical suspicion of infection at admission * Antibiotics already initiated in the current episode of care for any reason * Receipt of systemic antibiotics in the past 7 days * Meconium-stained liquor at presentation * Contraindication to vaginal delivery, including malpresentation, major placenta praevia, maternal refusal of trial of labour after caesarean, or known absolute indication for elective lower segment caesarean section * Known Group B Streptococcus colonisation in the current pregnancy, including positive rectovaginal swab or bacteriuria * Abnormal cardiotocography on admission requiring expedited delivery * Allergy or contraindication to penicillin or aminoglycosides * Renal impairment defined as creatinine clearance less than 30 mL/min * Known renal disease * Known ototoxicity risk or vestibular/cochlear disorders * Unknown timing of prelabour rupture of membranes * Multiple gestation * Major fetal anomaly

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rupture of membranes prior to onset of labor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Miri Hospital

    Miri, Sarawak, 98000, Malaysia

  • Sarawak General Hospital

    Kuching, Sarawak, 93586, Malaysia

  • Sarikei Hospital

    Sarikei, Sarawak, 96100, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.